[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

WaferGen Biosystems, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WaferGen Biosystems, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wai Yuen Tong Medicine Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wai Yuen Tong Medicine Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wakamoto Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wakamoto Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Walvax Biotechnology Co.,Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Walvax Biotechnology Co.,Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wanbury Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wanbury Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Warner Chilcott plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Warner Chilcott plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Warnex Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Warnex Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Waters Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Waters Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Watson Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Watson Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

WayPoint Biomedical Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WayPoint Biomedical Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Welcure Drugs & Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Welcure Drugs & Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Welichem Biotech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Welichem Biotech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wex Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wex Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Whanin Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Whanin Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wilex AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wilex AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

William Ransom & Son plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

William Ransom & Son plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Winston Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Winston Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wintac Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wintac Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wockhardt Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wockhardt Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

WooGene B&G Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WooGene B&G Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wool Equities Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wool Equities Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wooridul Life Sciences Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wooridul Life Sciences Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wooridul Pharmaceutical Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wooridul Pharmaceutical Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Worldwide Biotech & Pharmaceutical Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Worldwide Biotech & Pharmaceutical Company Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wuhan Humanwell Hi-tech Industry Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wuhan Humanwell Hi-tech Industry Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wuhan Jianmin Pharmaceutical Group Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wuhan Jianmin Pharmaceutical Group Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wuhan National Pharmaceutical Technology Company Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wuhan National Pharmaceutical Technology Company Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

WuXi PharmaTech (Cayman) Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WuXi PharmaTech (Cayman) Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wuyi International Pharmaceutical Company Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wuyi International Pharmaceutical Company Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wyeth Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wyeth Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Wyeth Pakistan Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wyeth Pakistan Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Xceed Capital Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xceed Capital Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Xenacare Holdings Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenacare Holdings Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Xeno Transplants Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xeno Transplants Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Xenoport, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenoport, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

XLR Medical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

XLR Medical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

XOMA Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

XOMA Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

XTL Biopharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

XTL Biopharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Yabao Pharmaceutical Group Co.,Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Yabao Pharmaceutical Group Co.,Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

YanTai Yuancheng Enterprise Group CO.,LTD Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

YanTai Yuancheng Enterprise Group CO.,LTD Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

YM BioSciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

YM BioSciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

YSP Southeast Asia Holdings Bhd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

YSP Southeast Asia Holdings Bhd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Yuhan Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Yuhan Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Yung Shin Pharmaceutical Industries Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Yung Shin Pharmaceutical Industries Co. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Yung Zip Chemical Industry Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Yung Zip Chemical Industry Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Yungjin Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Yungjin Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Yunnan Baiyao Group Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Yunnan Baiyao Group Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Yuyu Pharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Yuyu Pharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Zalicus Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Zalicus Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Zandu Realty Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Zandu Realty Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers